Crossmark

Treatment of non-small cell lung cancer using chem-bioinformatics-driven engineering of exosomal cargo-vehicle for telmisartan and pioglitazone targeted-delivery

Crossref DOI link: https://doi.org/10.1038/s41598-025-10416-0

Published Online: 2025-07-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hamdy, Nadia M. https://orcid.org/0000-0003-2105-107X
Sanad, Eman F.

Kassab, Shaymaa E. https://orcid.org/0000-0002-4789-2662
Essam, Merhan

Guirguis, Monica A.

Basalious, Emad B.

Sultan, Ahmed S.
Funding

Funding for this research was provided by:

Ain Shams University
License Information

Text and Data Mining valid from 2025-07-11

Version of Record valid from 2025-07-11
More Information

Article History

Received: 11 February 2025

Accepted: 3 July 2025

First Online: 11 July 2025

Declarations

:

: The authors declare no competing interests.

: Not Applicable.

Document is current

Any future updates will be listed below